ArticleTranslational lung cancer research2026
Activity and specificity of KRAS variants-directed Revolution Medicines Company (RMC) compounds for pleural effusion-derived non-small cell lung cancer cell lines.
Sandra Stickler et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.